Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0RWPZE)
| ADC Name |
Belantamab-Compound (Ie)
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Belantamab Compound (Ie)
Click to Show/Hide
|
|||||
| Organization |
Orum Therapeutics, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Belantamab
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)
|
Antigen Info | ||||
| Payload Name |
Belantamab-Compound (Ie) payload
|
|||||
| Linker Name |
Belantamab-Compound (Ie) linker
|
|||||